Beckerman, Pazit, Yi-An Ko, and Katalin Susztak. “Epigenetics: a new way to look at kidney diseases.” Nephrology Dialysis Transplantation 29.10 (2014): 1821-1827.
Bechtel, Wibke, et al. “Methylation determines fibroblast activation and fibrogenesis in the kidney.” Nature medicine 16.5 (2010): 544.
Blasco, Maria A. “Telomeres and human disease: ageing, cancer and beyond.” Nature Reviews Genetics 6.8 (2005): 611.
Brilli, Lauren L., et al. “HDAC inhibitors in kidney development and disease.” Pediatric nephrology 28.10 (2013): 1909-1921.
Cañadas-Garre, M., et al. “Genomic approaches in the search for molecular biomarkers in chronic kidney disease.” Journal of translational medicine 16.1 (2018): 292.
Chen, Jing, et al. “Elevated Klotho promoter methylation is associated with severity of chronic kidney disease.” PloS one8.11 (2013): e79856.
Chung AC, Dong Y, Yang W, Zhong X, Li R, Lan HY. “Smad7 suppresses renal fibrosis via altering expression of TGF-beta/Smad3-regulated microRNAs.” Mol Ther. 2013;21:388–98
De Grey, Aubrey, and Michael Rae. Ending aging: The rejuvenation breakthroughs that could reverse human aging in our lifetime. St. Martin’s Press, 2007.
Hadden, Mitchell, and Andrew Advani. “Histone Deacetylase Inhibitors and Diabetic Kidney Disease.” International journal of molecular sciences 19.9 (2018): 2630.
Harley, Calvin B., et al. “A natural product telomerase activator as part of a health maintenance program.” Rejuvenation research 14.1 (2011): 45-56.
Hu, Ming Chang, et al. “Klotho deficiency causes vascular calcification in chronic kidney disease.” Journal of the American Society of Nephrology 22.1 (2011): 124-136.
Ko, Yi-An, et al. “Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development.” Genome biology 14.10 (2013): R108.
Ko, Yi-An, and Katalin Susztak. “Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease?.” Seminars in nephrology. Vol. 33. No. 4. WB Saunders, 2013.
Komorowsky, Claudiu, Matthias Ocker, and Margarete Goppelt‐Struebe. “Differential regulation of connective tissue growth factor in renal cells by histone deacetylase inhibitors.” Journal of cellular and molecular medicine 13.8b (2009): 2353-2364.
Kuro-o, Makoto. “Klotho and the aging process.” The Korean journal of internal medicine 26.2 (2011): 113.
Kordinas, Vasileios, Anastasios Ioannidis, and Stylianos Chatzipanagiotou. “The telomere/telomerase system in chronic inflammatory diseases. Cause or effect?.” Genes 7.9 (2016): 60.
Lorenzen, Johan M., Hermann Haller, and Thomas Thum. “MicroRNAs as mediators and therapeutic targets in chronic kidney disease.” Nature Reviews Nephrology 7.5 (2011): 286.
McGuinness, Dagmara, et al. “Identification of molecular markers of delayed graft function based on the regulation of biological ageing.” PloS one 11.1 (2016): e0146378.
Monickaraj, Finny, et al. “Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes.” Molecular and cellular biochemistry 365.1-2 (2012): 343-350.
Noh, Hyunjin, et al. “Histone deacetylase-2 is a key regulator of diabetes-and transforming growth factor-β1-induced renal injury.” American Journal of Physiology-Renal Physiology297.3 (2009): F729-F739.
Reidy, Kimberly, et al. “Molecular mechanisms of diabetic kidney disease.” The Journal of clinical investigation 124.6 (2014): 2333-2340.
Saal, Samuel, and Scott J. Harvey. “MicroRNAs and the kidney: coming of age.” Current opinion in nephrology and hypertension 18.4 (2009): 317-323.
Thum, Thomas, et al. “MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.” Nature 456.7224 (2008): 980.
Trionfini, Piera, Ariela Benigni, and Giuseppe Remuzzi. “MicroRNAs in kidney physiology and disease.” Nature Reviews Nephrology 11.1 (2015): 23.
Van Beneden, Katrien, et al. “HDAC inhibitors in experimental liver and kidney fibrosis.” Fibrogenesis & tissue repair 6.1 (2013): 1.
Wills, Lauren P., and Rick G. Schnellmann. “Telomeres and telomerase in renal health.” Journal of the American Society of Nephrology 22.1 (2011): 39-41.
Wing, Maria R., et al. “Epigenetics of progression of chronic kidney disease: fact or fantasy?.” Seminars in nephrology. Vol. 33. No. 4. WB Saunders, 2013.
